Real Time Continuous Blood Monitoring(news.stanford.edu) |
Real Time Continuous Blood Monitoring(news.stanford.edu) |
> Here we show that multiple analytes can be continuously and simultaneously measured with picomolar sensitivity and sub-second resolution via the integration of aptamers and antibodies into a bead-based fluorescence sandwich immunoassay implemented in a custom microfluidic chip. After an incubation time of 30 s, bead fluorescence is measured using a high-speed camera under spatially multiplexed two-colour laser illumination.
> Incoming beads are first illuminated by a red laser, which interrogates the Cy5 fluorescence intensity indicating the glucose concentration. This is followed by illumination with a green laser that interrogates the R-PE fluorescence intensity, which measures the insulin concentration. We used an exposure time of 50 ms and acquired images every 100 ms.
> To allow for real-time analysis, RT-ELISA requires a continuous supply of reagents, which corresponds to approximately US$10.50 worth of reagents consumed for a 1-h run.
> The detection scheme will also need to be miniaturized to reduce its complexity, most notably with regard to the camera and other optical components. However, we believe that such miniaturization would be possible with integrated photonics and that further advances in these technologies could make RT-ELISA suitable for bedside patient monitoring.
On wiki [0] I see:
> In the most simple form of an ELISA, antigens from the sample to be tested are attached to a surface. Then, a matching antibody is applied over the surface so it can bind the antigen. This antibody is linked to an enzyme and then any unbound antibodies are removed. In the final step, a substance containing the enzyme's substrate is added. If there was binding the subsequent reaction produces a detectable signal, most commonly a color change.
What are the pain points in this process?
Also figuring out how to reliably manufacture these to within a certain tolerance is a very difficult feat of engineering.
I haven’t been active in this field for a while though, so these may no longer be issues.
Does anyone know of any work being done in this area and what the challenges are ?
"Interstitial fluid consists of a water solvent containing sugars, salts, fatty acids, amino acids, coenzymes, hormones, neurotransmitters, white blood cells and cell waste-products."
https://en.wikipedia.org/wiki/Extracellular_fluid#Interstiti...
Theranos was claiming they were already delivering the full spectrum of tests when the promise is still not fullfillable.
Alternatively, realistically focusing on a single miniaturized test or two until you get consistency with the established reference instruments could provide the foundation for a worthwhile investment by comparison.
Do you happen to know of others?